.logo { width: 120px; height: 28px; opacity: 0.6; } .header-container { height: 50px; background: #302D2A; } .logo-container { position: absolute; display: flex; color: #fff; left: 130px; top: 10px; } .logo-container p { margin: auto; padding-left: 20px; } .titleBar-button_fmuucnv.titleBar-button_fmuucnv, .titleBar-button_fmuucnv.titleBar-button_fmuucnv:hover:not(:disabled), .titleBar-button_fmuucnv.titleBar-button_fmuucnv:focus, .titleBar-button_fmuucnv.titleBar-button_fmuucnv:focus:not(.focus-visible), .titleBar-button_fmuucnv.titleBar-button_fmuucnv:active:not(:disabled), .titleBar-button_fmuucnv.titleBar-button_fmuucnv.isOpen, .titleBar-button_fmuucnv.titleBar-button_fmuucnv.isOpen:focus, .titleBar-button_fmuucnv.titleBar-button_fmuucnv.isOpen.focus-visible { color: #fff !important; } .footbar-container { height: 80px; } .footbar-subcontainer { position: relative; height: 80px; background: #CEAA8F; display: flex; align-items: center; justify-content: center; } .footbar-subcontainer p { color: #302D2A; font-size: 20px; margin-right: 10px; } body { font-family: Oracle Sans; } .About.P { background-size: cover; background-image: url(https://us.v-cdn.net/6032253/uploads/815/QURW3A01AKVP.png) } body.Section-Profile .ProfileOptions .ButtonGroup a { background: #302D2A; border-radius: 50px; color: #fff; } body.Section-Profile .Profile dd, body.Section-Profile .Profile dt { color: #100F0E; } .BreadcrumbsBox .Breadcrumbs a { color: #302D2A; font-family: Oracle Sans; } .BreadcrumbsBox { max-width: 1264px; padding-left: 40px; padding-right: 40px; margin: 0 auto; } .ReactionsWrap.H { color: #100F0E; font-weight: 800; } body.Section-Profile .CountItemWrap { width: 95px; margin: 14px; } body.Section-Profile .CountItemWrap .CountTotal { color: #A1ADAF; font-family: Oracle Sans; font-style: normal; font-weight: normal; font-size: 48px; } body.Section-Profile .CountItemWrap .CountLabel { font-family: Oracle Sans; font-style: normal; font-weight: normal; font-size: 16px; } .BoxFilter ul.FilterMenu li.Active a{ background: #302D2A; color: #fff; padding: 5px; } .BoxFilter ul.FilterMenu li a{ font-family: Oracle Sans; font-style: normal; font-weight: 600; font-size: 17px; color: #41727E; } @media screen and (max-width: 768px) { .logo { margin: 0 auto; } } @media screen and (max-width: 480px) { .footbar-container { height: auto; } .footbar-subcontainer { display: block; height: auto; } .footbar-subcontainer p { font-weight: bold; font-size: 26px; line-height: 34px; color: #fff; padding: 20px; } } .logo { width: 120px; height: 28px; opacity: 0.6; } .header-container { height: 50px; background: #302D2A; } .logo-container { position: absolute; display: flex; color: #fff; left: 130px; top: 10px; } .logo-container p { margin: auto; padding-left: 20px; } .footbar-container { height: 80px; } .footbar-subcontainer { position: relative; height: 80px; background: #CEAA8F; display: flex; align-items: center; justify-content: center; } .footbar-subcontainer p { color: #302D2A; font-size: 20px; margin-right: 10px; } .About.P { background-size: cover; background-image: url(https://us.v-cdn.net/6032253/uploads/815/QURW3A01AKVP.png) } body.Section-Profile .ProfileOptions .ButtonGroup a { background: #302D2A; border-radius: 50px; color: #fff; } body.Section-Profile .Profile dd, body.Section-Profile .Profile dt { color: #100F0E; } .breadcrumb-container .BreadcrumbsBox .Breadcrumbs a { color: #FFFFFF !important; } .BreadcrumbsBox .Breadcrumbs a { color: #302D2A; font-family: Oracle Sans; } .ReactionsWrap.H { color: #100F0E; font-weight: 800; } body.Section-Profile .CountItemWrap { width: 95px; margin: 14px; } body.Section-Profile .CountItemWrap .CountTotal { color: #A1ADAF; font-family: Oracle Sans; font-style: normal; font-weight: normal; font-size: 48px; } body.Section-Profile .CountItemWrap .CountLabel { font-family: Oracle Sans; font-style: normal; font-weight: normal; font-size: 16px; } .BoxFilter ul.FilterMenu li.Active a{ background: #302D2A; color: #fff; padding: 5px; } .BoxFilter ul.FilterMenu li a{ font-family: Oracle Sans; font-style: normal; font-weight: 600; font-size: 17px; color: #41727E; } @media screen and (max-width: 768px) { .logo { margin: 0 auto; } }

Life Sciences Insights Hub Life Sciences: Industry Hot Topics

Life Sciences: Industry Hot Topics

Is the current business model of Pharma companies outdated when it comes to rare diseases?
Written by Tim Irfan Business Lead, Rare Disease & Biotech The World Orphan Drug Congress (WODC) The World Orphan Drug Congress (WODC) is one of the largest of its kind This year, it has attracted attendees and speakers from the industry (Alexion, UCB, Pfizer, Takeda, Sanofi, to name a few), from regulatory bodies such as…
Getting to the heart of the matter
Written by Sarah Smith | Daniel Sterzi | Regina Gowindah The role of emotion in research. “The best and most beautiful things in the world cannot be seen or even touched. They must be felt with the heart”- Helen Keller - author As humans, we like to think that we are rational, that we make logical decisions. We…
Stigma: A vicious circle of burden for sufferers
Written by Sarah Smith | Nate Way | Jeanette Hodgson | Daniel Sterzi The experience of people suffering from irritable bowel syndrome (IBS) is often fraught with stigma, confusion, embarrassment, belittlement, and loneliness. Cerner Enviza conducted qualitative research with IBS sufferers in UK, US, Germany and China to…
We need to better understand the emotional impact of cancer
Written by Regina Gowindah | Yew Ying Jie | Victoria Tan A cancer diagnosis can put a huge psychological burden on patients and their caregivers. Cerner Enviza is collaborating on a research study with the National Cancer Centre Singapore (NCCS) to better understand this issue and help to advance cancer care. Why the…
United BioSource, LLC selects Oracle Argus Cloud, paves path forward for future safety technology
By Michael McCann | Global Vice President Sales, Alliances and Channels Safety is the cornerstone of clinical trials but capturing and reporting adverse events is a challenge. United BioSource, LLC (UBC), the leading provider of evidence-based research for the biopharma industry, has migrated its safety functions from…